Gefitinib versus docetaxel in previously treated non-small-cell lung cancer (INTEREST): a randomised phase III trialEdward S. Kim, Jean‐Yves Douillard, Radj Gervais et al.|The Lancet|2008Cited by 1.2k
The International Association for the Study of Lung Cancer Global Survey on Molecular Testing in Lung CancerMatthew P. Smeltzer, Fred R. Hirsch, Murry W. Wynes et al.|Journal of Thoracic Oncology|2020Cited by 184